Live-single-cell phenotypic cancer biomarkers-future role in precision oncology?
Abstract The promise of precision and personalized medicine is rooted in accurate, highly sensitive, and specific disease biomarkers. This is particularly true for cancer-a disease characterized by marked tumor heterogeneity and diverse molecular signatures. Although thousands of biomarkers have bee...
Main Authors: | Grannum R. Sant, Kevin B. Knopf, David M. Albala |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2017-06-01
|
Series: | npj Precision Oncology |
Online Access: | https://doi.org/10.1038/s41698-017-0025-y |
Similar Items
-
Single-Cell Transcriptomics in Cancer Immunobiology: The Future of Precision Oncology
by: Fatima Valdes-Mora, et al.
Published: (2018-11-01) -
Precision Oncology and Cancer Biomarkers Issues at Stake and Matters of Concern
Published: (2022) -
Precision oncology- the future of personalized cancer medicine?
by: Ann M. Bode, et al.
Published: (2017-03-01) -
An Emerging Role for Radiation Oncology in Precision Oncology
by: Sharad Goyal, et al.
Published: (2016-03-01) -
DNA-protein biomarkers for immunotherapy in the era of precision oncology
by: Binnari Kim, et al.
Published: (2021-01-01)